Division of Geriatric Medicine, Groote Schuur Hospital & Institute of Ageing in Africa, Cape Town, South Africa.
Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
BMC Geriatr. 2023 Dec 9;23(1):829. doi: 10.1186/s12877-023-04536-3.
There are no published longitudinal studies from Africa of people with dementia seen in memory clinics. The aim of this study was to determine the proportions of the different dementia subtypes, rates of cognitive decline, and predictors of survival in patients diagnosed with dementia and seen in a memory clinic.
Data were collected retrospectively from clinic records of patients aged ≥ 60 seen in the memory clinic at Groote Schuur Hospital, Cape Town, South Africa over a 10-year period. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria were used to identify patients with Major Neurocognitive Disorders (dementia). Additional diagnostic criteria were used to determine the specific subtypes of dementia. Linear regression analysis was used to determine crude rates of cognitive decline, expressed as mini-mental state examination (MMSE) points lost per year. Changes in MMSE scores were derived using mixed effects modelling to curvilinear models of cognitive change, with time as the dependent variable. Multivariable cox survival analysis was used to determine factors at baseline that predicted mortality.
Of the 165 patients who met inclusion criteria, 117(70.9%) had Major Neurocognitive Disorder due to Alzheimer's disease (AD), 24(14.6%) Vascular Neurocognitive Disorder (VND), 6(3.6%) Dementia with Lewy Bodies (DLB), 5(3%) Parkinson disease-associated dementia (PDD), 3(1.8%) fronto-temporal dementia, 4(2.4%) mixed dementia and 6(3.6%) other types of dementia. The average annual decline in MMSE points was 2.2(DLB/PDD), 2.1(AD) and 1.3(VND). Cognitive scores at baseline were significantly lower in patients with 8 compared to 13 years of education and in those with VND compared with AD. Factors associated with shorter survival included age at onset greater than 65 (HR = 1.82, 95% C.I. 1.11, 2.99, p = 0.017), lower baseline MMSE (HR = 1.05, 95% C.I. 1.01, 1.10, p = 0.029), Charlson's comorbidity scores of 3 to 4 (HR = 1.88, 95% C.I. 1.14, 3.10, p = 0.014), scores of 5 or more (HR = 1.97, 95% C.I. 1.16, 3.34, p = 0.012) and DLB/PDD (HR = 3.07, 95% C.I. 1.50, 6.29, p = 0.002). Being female (HR = 0.59, 95% C.I.0.36, 0.95, p = 0.029) was associated with longer survival.
Knowledge of dementia subtypes, the rate and factors affecting cognitive decline and survival outcomes will help inform decisions about patient selection for potential future therapies and for planning dementia services in resource-poor settings.
目前尚无来自非洲的关于在记忆门诊就诊的痴呆症患者的纵向研究。本研究旨在确定在南非开普敦格罗特舒尔医院的记忆诊所就诊的被诊断为痴呆症的患者中不同痴呆亚型的比例、认知能力下降的速度以及生存的预测因素。
从格罗特舒尔医院记忆诊所的 10 年期间就诊的年龄≥60 岁的患者的临床记录中回顾性收集数据。使用《精神障碍诊断与统计手册》(DSM-5)标准来确定患有主要神经认知障碍(痴呆症)的患者。使用额外的诊断标准来确定痴呆症的具体亚型。线性回归分析用于确定认知能力下降的粗率,用每年丢失的迷你精神状态检查(MMSE)分数表示。使用混合效应模型从 MMSE 分数的变化中得出认知变化的曲线模型,以时间为因变量。多变量 Cox 生存分析用于确定基线时预测死亡率的因素。
在符合纳入标准的 165 名患者中,117 名(70.9%)患有阿尔茨海默病(AD)所致的主要神经认知障碍,24 名(14.6%)患有血管性神经认知障碍(VND),6 名(3.6%)患有路易体痴呆(DLB),5 名(3%)患有帕金森病相关痴呆(PDD),3 名(1.8%)患有额颞叶痴呆,4 名(2.4%)患有混合性痴呆,6 名(3.6%)患有其他类型的痴呆。MMSE 分数每年下降 2.2(DLB/PDD)、2.1(AD)和 1.3(VND)。与接受 8 年教育相比,接受 13 年教育的患者以及与 AD 相比,VND 患者的基线认知评分显著较低。与较短的生存时间相关的因素包括发病年龄大于 65 岁(HR=1.82,95%CI 1.11,2.99,p=0.017)、基线 MMSE 较低(HR=1.05,95%CI 1.01,1.10,p=0.029)、Charlson 合并症评分 3 至 4 分(HR=1.88,95%CI 1.14,3.10,p=0.014)、评分 5 分或以上(HR=1.97,95%CI 1.16,3.34,p=0.012)和 DLB/PDD(HR=3.07,95%CI 1.50,6.29,p=0.002)。女性(HR=0.59,95%CI 0.36,0.95,p=0.029)与生存时间较长相关。
了解痴呆症亚型、认知能力下降的速度以及影响认知能力下降和生存结果的因素,将有助于为潜在的未来治疗方法选择患者和规划资源匮乏环境中的痴呆症服务提供信息。